 Takeda Pharmaceutical Company Limited NYSE:TAK Q2 2022 Results Conference Call October 27, 2022 5:30 AM ET Company Participants Ayako Iwamuro - IR Christophe Weber - President and CEO Andrew Plump - President, RD Costa Saroukos - CFO Ramona Sequeira - President, Global Portfolio Division Teresa Bitetti - President, Global Oncology Business Unit Julie Kim - President, US Business Unit Giles Platford - President, Plasma-Derived Therapies Business Unit Masato Iwasaki - Representative Director, Japan General Affairs Conference Call Participants Hidemaru Yamaguchi - Citi Stacy Ku - Cowen Motoya Koutani - Nomura Securities Shinichiro Muraoka - Morgan Stanley Seiji Wakao - J.P. Morgan Fumiyoshi Sakai - Credit Suisse Securities Akinori Ueda - Goldman Sachs Securities Naomi Kumagai - Mitsubishi UFJ Morgan Stanley Hiroaki Hashimoto - Nikkei BP Ayako Iwamuro Thank you very much for taking time out of your busy schedule to join us today for Takedas Financial Results Webinar for the Second Quarter of Fiscal Year 2022. 